DIFFERENTIAL EFFICACY OF BORTEZOMIB IN SUBTYPES OF DIFFUSE LARGE B‐CELL LYMPHOMA (DLBL): a PROSPECTIVE RANDOMISED STUDY STRATIFIED BY TRANSCRIPTOME PROFILING: REMODL‐B. (June 2017)

• Record Type: Journal Article
• Authors: Davies, A.J.; Barrans, S.; Maishman, T.; Cummin, T.E.; Bentley, M.; Mamot, C.; Novak, U.; Caddy, J.; Hamid, D.; Kazmi‐Stokes, S.H.; Mcmillan, A.; Fields, P.A.; Pocock, C.; Kruger, A.; Collins, G.; Sha, C.; Clipson, A.; Wang, M.; Tooze, R.M.; Care, M.A.; Griffiths, G.O.; Du, M.; Westhead, D.R.; Burton, C.; Jack, A.; Johnson, P.W.
• Is Part Of: Hematological oncology. Volume 35(2017)Supplement 2
• Page Start: 130
• Page End: 131
• Publication Date: 2017-06
• Subjects: Hematological oncology -- Periodicals; Hematology; Medical Oncology; 616.99418005
• DOI: 10.1002/hon.2437_120
• Languages: English
• ISSNs: 0278-0232